These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8794405)
1. Stability of p53 tumor suppressor gene mutations during the process of metastasis and during chemotherapy. Taniguchi Y; Gemma A; Takeda Y; Takenaka K; Niitani H; Kudoh S; Shimada T Lung Cancer; 1996 Jun; 14(2-3):219-28. PubMed ID: 8794405 [TBL] [Abstract][Full Text] [Related]
2. [p53 gene abnormalities in advanced primary lung cancer and metastatic tumors]. Taniguchi Y Nihon Ika Daigaku Zasshi; 1995 Jun; 62(3):241-50. PubMed ID: 7615696 [TBL] [Abstract][Full Text] [Related]
3. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408 [TBL] [Abstract][Full Text] [Related]
4. Lack of concordant p53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis. Zhang SY; Bauer B; Mitsunaga S; Goodrow TL; Klein-Szanto AJ Mol Carcinog; 1995 Feb; 12(2):77-81. PubMed ID: 7662119 [TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Zhao Y; Wu D; Xiang X; Zhang B; Zhou N; Hu Y Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811 [TBL] [Abstract][Full Text] [Related]
6. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Noguchi M; Maezawa N; Nakanishi Y; Matsuno Y; Shimosato Y; Hirohashi S Diagn Mol Pathol; 1993 Mar; 2(1):29-35. PubMed ID: 8287223 [TBL] [Abstract][Full Text] [Related]
7. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
8. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284 [TBL] [Abstract][Full Text] [Related]
9. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance. Niwa K; Itoh M; Murase T; Morishita S; Itoh N; Mori H; Tamaya T Br J Cancer; 1994 Dec; 70(6):1191-7. PubMed ID: 7981076 [TBL] [Abstract][Full Text] [Related]
10. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer. Dahiya R; Deng G; Chen KM; Chui RM; Haughney PC; Narayan P Br J Cancer; 1996 Jul; 74(2):264-8. PubMed ID: 8688333 [TBL] [Abstract][Full Text] [Related]
11. p53 mutations in primary human lung tumors and their metastases. Reichel MB; Ohgaki H; Petersen I; Kleihues P Mol Carcinog; 1994 Feb; 9(2):105-9. PubMed ID: 8142008 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Sameshima Y; Matsuno Y; Hirohashi S; Shimosato Y; Mizoguchi H; Sugimura T; Terada M; Yokota J Oncogene; 1992 Mar; 7(3):451-7. PubMed ID: 1312700 [TBL] [Abstract][Full Text] [Related]
13. [Detection of p53 mutation using PCR-SSCP silver staining method]. Zhao W; Si J; Li K; Zhang X; Song G Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159 [TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
15. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937 [TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
17. Association between p53 mutation and clinicopathological features of non-small cell lung cancer. Guang SG; Ogura T; Sekine I; Yokozaki M; Esumi H; Kodama T; Nagai K Jpn J Clin Oncol; 1997 Aug; 27(4):211-5. PubMed ID: 9379505 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Chiba I; Muthumala M; Yamazaki Y; Uz Zaman A; Iizuka T; Amemiya A; Shibata T; Kashiwazaki H; Sugiura C; Fukuda H Int J Cancer; 1998 Sep; 77(6):839-42. PubMed ID: 9714051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]